Free delivery within Poland with upfront payment starting from purchases of 200 PLN! - Fast shipping worldwide - see menu for details

Chemical reagents

Professional supplies for your laboratory

Bromantan - Educational material

Bromantane is a synthetic organic compound belonging to adamantane derivatives. Its molecule contains a spatial adamantane skeleton and a ring with an attached bromine atom. Both parts are connected by a nitrogen atom. In English-language sources, the spellings bromantan and bromantane can be found. Source: PubChem — Bromantane.

In research literature, bromantane appears, among other places, in papers concerning dopamine, the enzymes involved in its synthesis, and signal transmission between nerve cells. Understanding these publications requires distinguishing between several processes. Dopamine synthesis, its release, reuptake, and interaction with receptors do not mean the same thing.

The following description focuses on compound construction and the basics of mechanism interpretation. It explains what individual measurements indicate, without attributing broader meaning to them than what stems from the type of test. It does not present application schemes or a catalog of health benefits.

What do the names bromantan and Ladasten mean?

Table of contents

Bromantan is the name of a chemical substance. Ladasten is a trade name that also appears in the titles of scientific publications. Knowing it helps to find older papers, but in the chemical description it is more important to determine what compound and what material were actually studied.

The name N-(4-bromophenyl)adamantan-2-amine can also be found in sources. It indicates the parts of the molecule and the way they are connected. The longer notation does not mean a different substance just because it looks different from the short name bromantane.

However, when comparing publications, a distinction must be made between a substance and a ready-made multi-component material. A trade name does not automatically reveal all the components of a sample or the results of its analytical characterization.

What is an adamantane skeleton?

Adamantane is a hydrocarbon with a compact, spatial structure resembling a small cage. The word „cage” here describes the arrangement of bonded carbon atoms. It does not mean a container in which another component of bromantane is enclosed.

Unlike a simple chain, such a backbone has limited freedom of conformational change. However, one should not conclude from this that the entire bromantane molecule is completely rigid. Its individual parts may have different degrees of freedom in their orientation relative to one another.

Membership in the adamantane derivatives describes a common structural element. It does not imply identical properties for all compounds in this group. Additional fragments, their attachment sites, and types of bonds are equally important for the identity of the substance.

Where is bromine located?

The bromine atom in bromantane is attached to the phenyl ring. The term „4-bromophenyl” indicates its position relative to the point of attachment of the ring to the nitrogen atom. In older nomenclature, the term „para” can also be found.

Bromine is part of the compound's structure here, not a separate bromide ion acting as a salt counterion. This is an important distinction. A brominated molecule and the bromide of another substance are not the same type of chemical material.

Nor should bromantane be attributed the properties of other bromine-containing substances solely based on the presence of this element. Its chemical environment and entire structure matter. A shared atom does not establish a shared biological mechanism.

Is bromantane a peptide?

Bromantane is not a peptide or a protein. It does not contain a chain of amino acid residues for which a sequence could be given. Its structure is described using an adamantane skeleton, a bromophenyl fragment, and a connecting nitrogen atom.

The presence of nitrogen in a molecule is not sufficient to classify a substance as a peptide. Nitrogen occurs in many other groups of organic compounds. The classification is determined by the way the atoms are bonded, not merely the presence of a given element.

In bromantane, the nitrogen atom is bonded to two carbon groups and a hydrogen atom, which corresponds to the structure of a secondary amine. The term „secondary” refers to this chemical arrangement, not to the importance or quality of the substance.

Molecular formula and molar mass of bromantan

The empirical formula of bromantane is C₁₆H₂₀BrN, and the molar mass is approximately 306.24 g/mol. Carbon, hydrogen, bromine, and azot are included in the record. For this structure, PubChem provides the CID identifier 4660557. Source: PubChem — Bromantane.

The molecular formula indicates the number of atoms, but does not show their connections by itself. Therefore, it is supplemented with a structural name or a drawing. Mass compatibility alone also does not always determine whether two materials have an identical structure.

The molar mass is not a measure of biological activity or sample quality. It does not determine purity, water content, or the presence of other components. The parameters of the molecule and the parameters of the tested material as a whole answer different questions.

Bromantane and other adamantane derivatives

In publications, bromantane is sometimes grouped with other compounds containing an adamantane skeleton. Such a comparison can be useful for discussing structural similarities, but it does not justify transferring the mechanism of one compound to another.

The common fragment constitutes only a part of the molecule. Changing the attached group can affect interactions with proteins and the environment. However, it is not possible to predict all differences or their magnitude based solely on a change in the drawing.

For this reason, the description of bromantane should be based on data concerning bromantane. Information about another member of the family may provide context, but it does not replace the direct identification of the molecular target or the measurement performed for the substance in question.

Why does dopamine appear in research?

Dopamine is a compound involved in signal transmission. In the nervous system, its significance depends on the location, cell type, and receptors. It is not a single indicator from which mood, motivation, or cognitive abilities can be directly read.

Bromantane research included, among other things, the amount of dopamine and elements of its synthesis pathway. Mikhaylova and colleagues evaluated various brain areas in rats by measuring tyrosine hydroxylase mRNA and protein, as well as dopamine and L-DOPA. The results did not constitute a single uniform measurement of the entire brain. Source: Mikhaylova et al., 2007.

This explains why the term „impact on the dopaminergic system” requires clarification. It can refer to different stages and different sites that are not interchangeable.

How is dopamine produced?

In the basic description of its biosynthesis, tyrosine is converted into L-DOPA and then into dopamine. The reactions require the participation of enzymes. Tyrosine hydroxylase participates in the first of these steps, and aromatic L-amino acid decarboxylase in the next.

Bromantane is none of these three compounds. It should not be presented as a building block that simply turns into dopamine. The question of its effect on the process of its creation is different from the question of being a direct precursor.

Knowing the successive stages helps to read the results of experiments. Changing the amount of L-DOPA can provide information about the pathway, but its interpretation also depends on what happens to L-DOPA next. The accumulation of an intermediate compound does not always mean a greater amount of the final product.

What do the abbreviations TH, DDC, and AADC stand for?

TH is an abbreviation used for tyrosine hydroxylase. DDC refers to DOPA decarboxylase, and AADC to aromatic L-amino acid decarboxylase. The latter two terms in this context refer to the same enzyme, whose role is not limited to a single substrate.

Term What does it describe in the discussed trail?
Tyrosine Starting compound for the presented steps
Thailand Enzyme involved in the production of L-DOPA
L-DOPA Indirect association
DDC / AADC The enzyme that converts L-DOPA to dopamine
Dopamine The product of these steps and the signaling molecule

The table organizes names rather than presenting instructions for changing this pathway. Substances, enzymes, and reaction products have different roles, even though they appear side by side in a single description.

Gene expression, protein amount and enzyme activity

Gene expression means utilizing the information stored within it. In an experiment, for example, the amount of mRNA—the molecules that intermediate in transmitting the information needed to produce a protein—can be measured. Such a result is not yet a direct measurement of enzyme activity.

Separately, the amount of protein itself can be labeled. Even then, the question remains as to how actively it participates in the reaction. The course of the process is also influenced by the availability of substrates, required auxiliary components, and conditions within the cell.

Therefore, in the description of bromantane, the sentence about mRNA change should not be turned into a guarantee of a specific increase in dopamine production. Subsequent levels are connected, but each requires an appropriate measurement. Furthermore, a change in expression does not automatically mean a change in the DNA sequence.

Synthesis, release and reuptake

Synthesis means the production of dopamine through chemical reactions. Release refers to its transition from the cell into the space where it can participate in signaling. Reuptake involves the transport of dopamine from this space back into the cells.

These stages can be compared to creating a message, sending it, and deleting it from the receiving location. The comparison is simplified, but it shows why changing one stage is not a measurement of all the rest.

The work of Zimin et al. describes studies on the biosynthesis, release, and transport of dopamine in various experimental systems related to the rat brain. The authors demonstrated, among other things, the inhibition of active dopamine transport in a nerve terminal preparation. Therefore, bromantane should not be presented solely through the categorical assertion that it cannot affect reuptake. Source: Zimin et al., 2010.

A receptor is not the same as a transporter

The receptor receives the signal, while the transporter participates in the transport of substances. These proteins may cooperate in the regulation of the dopaminergic system, but they perform different tasks. A change in dopamine transport does not automatically mean the direct stimulation of its receptors by bromantane.

In the aforementioned work by Zimin et al., no direct effect on the studied dopamine D1, D2, and D3 receptors was demonstrated in the applied in vitro model. The scope of this result must be kept in mind: it concerned specific receptors and conditions, rather than all possible interactions of the substance. Source: Zimin et al., 2010.

Indirect signaling effects can occur without direct interaction with the receptor. However, the word „indirect” alone does not indicate whether the effect is weaker, longer-lasting, or risk-free.

Why do the brain region and type of sample matter?

There is no single, common dopamine reservoir in the brain whose contents describe all processes. Different areas contain different connection systems and serve distinct functions. A result for one area is not automatically a result for the others.

The type of sample is also important. Measurement in homogenized tissue includes its content within a specific range. Measurement of substances outside cells answers a different question. Their values should not be treated as two interchangeable ways of presenting the same quantity.

Therefore, in the article about bromantane, it is worth keeping the information on where and what was measured. The general statement „increases dopamine in the brain” can hide differences between the site of production, intracellular stores, and the signal available outside the cell.

What are synaptosomes and ex vivo studies?

Synaptosomes are preparations obtained from neural tissue containing isolated nerve endings. They enable the study of selected processes, such as neurotransmitter transport. They are not the whole brain or a full neural connectivity system.

The term ex vivo refers to the study of biological material outside the organism from which it was taken. It should not be confused with the direct measurement of everything that happens in a living organism. The history of the material and the conditions of subsequent determination are part of the interpretation.

In bromantane research, such models make it possible to isolate a specific process from many other phenomena. This is their advantage, but at the same time their limitation. The transport result in the preparation does not independently describe the behavior of the animal, let alone human experience.

What does synaptic plasticity mean?

Synaptic plasticity refers to changes in the way signals are transmitted at connections between nerve cells. One of its studied manifestations is the change in the strength of the response following a specific stimulation. This is not a direct test of human information memorization.

Mikhaylova et al. also investigated signaling in a hippocampal preparation. They described a change in the persistence of synaptic response potentiation and its dependence on protein synthesis and dopaminergic signaling. This is a mechanistic result from a specific model, not direct proof of memory improvement. Source: Mikhaylova et al., 2007.

It is also important to distinguish between the amplification of a single measured response and general „brain enhancement.” The latter term does not indicate a specific parameter and easily gives the result a meaning that the experiment did not test.

What can behavioral studies tell us about bromantane?

In animal experiments, specific behaviors are measured: movement, time spent in a part of the apparatus, or reaction to test conditions. These are observations that can be counted and compared. However, they are not a direct record of subjective feelings.

Various factors can influence the test result. Changes in motor activity may also alter the time spent in a given part of the maze. Therefore, interpretation requires taking into account what else was measured and what comparisons were made.

When describing bromantane, a single behavioral result should not be interpreted as automatic confirmation of a specific mental benefit in humans. Precise language preserves the value of the model without equating it with human experience.

What can be known from the very existence of human subjects research?

There are also publications in the literature concerning bromantane under the name Ladasten involving humans. An example is the work by Neznamov and coworkers presented as a placebo-controlled study. Therefore, the entire literature should not be described as exclusively animal-based. Source: Neznamov et al., 2009.

At the same time, the mere existence of such a publication does not confirm all the claims appearing in popular descriptions. The studied group, the method of comparison, the duration of observation, and the type of evaluated outcomes are what matters.

It is particularly unjustified to replace limited observation with an assurance of the complete absence of side effects or risk of addiction. Not observing an event in a given project and proving that it cannot occur are two different claims.

Frequently asked questions about bromantane

What is bromantan?

Bromantane is a synthetic adamantane derivative with the formula C₁₆H₂₀BrN. Its structure includes a spatial adamantane fragment and a bromophenyl fragment connected by a nitrogen atom. It is not a peptide or a mixture of amino acids. In literature, it appears under several name variants, so when searching, it is also worth including the spelling bromantane. The basic chemical description allows the compound to be recognized, but does not replace data on a specific sample. Structure, analytical identity, and the experimental result are related, yet distinct pieces of information.

Do bromantane and bromantan mean the same compound?

Bromantan and bromantane are spelling variants of the name of the same substance. The difference in the ending does not mean a change in structure. In documentation, however, it is worth checking the full name and identifier, because similar spelling is not always sufficient to identify the material. Additional terms may refer to a different compound or sample composition. The most helpful approach is to compare the name with the structural diagram and the analysis description, rather than treating every similar entry as proof of full equivalence of the materials.

Why does the name Ladasten appear in publications?

Ladasten is a trade name used in some publications concerning bromantane. Its presence in the title helps to find the literature, but it does not change the principles of study interpretation. It is still necessary to determine what material was used and what was measured. The trade name does not constitute an independent description of purity, structure, or all components of the product. In a neutral article, it can serve as information facilitating the retrieval of sources, without recommending the product or attributing the same properties to every sample.

What does an adamantane derivative mean?

It denotes a compound containing a structure derived from the spatial adamantane skeleton. In bromantane, it is connected to an additional fragment via a nitrogen atom. The common skeleton allows for comparing the structure of different substances, but does not establish a common mechanism for all derivatives. The attached groups are part of their identity and can alter interactions with the environment. Therefore, information about another adamantane compound should not be automatically presented as information about bromantane, even when their drawings have clear similarities.

Does the bromine in bromantane occur as a bromide?

A bromine atom is part of the bromophenyl moiety of the molecule. In this description, it does not act as a separate bromide ion forming a salt with another component. This is a difference in the way the atoms are bonded, not merely in the spelling of the name. For this reason, the characteristics of any given bromide salt cannot be attributed to bromantane. The properties of a substance stem from its entire structure. The presence of a single common element is not sufficient to predict its chemical or biological behavior.

Does bromantane convert directly into dopamine?

Bromantane is not a direct dopamine precursor in the described tyrosine–L-DOPA–dopamine pathway. Studies on its effects on elements of this pathway do not mean that the bromantane molecule becomes a dopamine molecule. A distinction must be made between a reaction substrate and a substance that influences a process. This is important when reading terms such as „effect on synthesis.” They describe a relationship with a biological process, and not automatically the provision of building blocks or the simple conversion of one named substance into another.

Are TH and DDC the same enzyme?

TH and DDC stand for different enzymes involved in successive stages of dopamine production. Tyrosine hydroxylase, or TH, participates in the conversion of tyrosine into L-DOPA. DDC, also referred to as AADC, is involved in the next step leading to dopamine. This distinction helps determine what a given measurement in a bromantane study refers to. The result for one enzyme is not automatically the result for the other, and a change in one step does not represent the full course of the entire pathway.

Does an increase in mRNA mean higher enzyme activity?

mRNA measurement concerns only one level of utilizing genetic information. It is not a direct measurement of the amount of finished protein or the rate of an enzymatic reaction. These quantities may be related, but they require appropriate assays. In the case of bromantane, observations regarding gene expression should not be turned into a definitive conclusion about every subsequent stage of dopamine synthesis. Substrate availability and cellular conditions are also important. Precisely indicating the measured quantity allows preserving the meaning of the result without oversimplification.

Are dopamine synthesis and its release the same process?

Synthesis describes the formation of dopamine, and release its transition from the cell into the space participating in signaling. The compound may already exist inside the cell before it is released. Therefore, the measurement of one of these activities does not replace the other. In publications about bromantane, it is important to check whether the amount of dopamine in the tissue, its availability outside cells, or the rate of a specific transformation was evaluated. Similar general terms can conceal different methods and different research questions.

Does indirect action mean no interaction with receptors?

Indirect impact on signaling means that the change in response may result from a process other than the direct stimulation of the receptor by the tested substance. This does not mean that receptors cease to participate in the further response of the system. In the case of bromantane, a distinction must be made between direct interaction and the consequences of changes related to dopamine. Likewise, the lack of a demonstrated effect on selected receptors in a specific model is not a finding that applies to all receptors. The scope of the conclusion should correspond to the scope of the experiment performed.

Does a higher amount of dopamine automatically mean an improved mood?

The amount of dopamine in a selected sample is not a simple mood scale. The significance of this molecule depends on the location, time, and the cells and receptors participating in the signaling. Therefore, a neurochemical result concerning bromantane should not be interpreted as a direct measurement of well-being. Examining a specific compound in tissue and assessing human experiences answer different questions. One can study the relationships between them, but establishing them requires data, not merely associating dopamine with colloquial terms for motivation or pleasure.

Is synaptic plasticity a measure of human memory?

Synaptic plasticity describes changes in signal transmission between nerve cells. It is an important neurobiological issue, but measuring responses in a tissue preparation is not a direct test of human memory. In bromantane research, this distinction must be maintained, even when the processes in question are relevant to the functioning of the nervous system. The persistence of a specific electrical response and the memorization of information by a participant are different outcomes. The former does not automatically establish the latter, nor does it determine its magnitude.

Does an animal test show its feelings?

A behavioral test allows observing and measuring behavior. It does not provide direct access to the animal's subjective experience. Model names may refer to phenomena related to anxiety or depression, but should not be interpreted as a full equivalence to the human psychological state. In the description of bromantane, it is worth stating which element of behavior was assessed and what other factors could have influenced the result. This keeps the observation understandable without attributing answers to broader clinical questions.

Does the absence of a reported incident prove the absence of risk?

Failure to observe a specific event in a study means that it was not demonstrated within the scope of that given project. It is not proof that it cannot occur under other conditions, after a different period of time, or in other individuals. This principle also applies to claims regarding bromantane. Particularly strong assurances about the complete absence of side effects or addiction require a much broader basis than a single observation. The literature description should maintain the distinction between the scope of available data and a universal guarantee of safety.

How to read a bromantane study without special preparation?

First, it is worth checking what material was studied and whether the experiment involved a tissue preparation, animals, or humans. Next, the measured variable should be identified: for example, mRNA, protein, dopamine, or behavior. Only then can one assess whether the conclusion corresponds to that measurement. This sequence helps to separate the name of the substance from the mechanism and interpretation. One does not need to know every abbreviation to notice that a result for a single brain area or a single test does not automatically describe all the properties of bromantane.

Disclaimer

The article is of an educational nature and concerns the structure of bromantane and the interpretation of selected mechanistic studies. It does not constitute medical advice, a purchase recommendation, or instructions for dosing, preparation, combination, or use of the substance. It is not used to evaluate a specific product. Laboratory results and the description of the mechanism do not independently confirm the safety or suitability of the material for human use. It is important to note that the article concerns the substance in general – it is not a description of a specific product (chemical reagent).

References

  1. National Center for Biotechnology Information. PubChem: Bromantane, CID 4660557. Identity, structure, and chemical parameters.
  2. Mikhaylova M., Vakhitova J.V., Yamidanov R.S., Salimgareeva M.Kh., Seredenin S.B., Behnisch T. (2007). The effects of ladasten on dopaminergic neurotransmission and hippocampal synaptic plasticity in rats. Neuropharmacology, 53(5), 601–608. DOI.
  3. Zimin I.A., Abaimov D.A., Budygin E.A., Zolotarev Iu.A., Kovalev G.I. (2010). Role of the brain dopaminergic and serotoninergic systems in psychopharmacological effects of ladasten and sydnocarb. Eksperimental'naia i Klinicheskaia Farmakologiia, 73(2), 2–5. Publication in Russian; English abstract.
  4. Neznamov G.G. et al. (2009). Ladasten, the new drug with psychostimulant and anxiolytic actions in treatment of neurasthenia (results of the comparative clinical study with placebo). Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova, 109(5), 20–26. Cited to indicate the type of existing literature, without presenting the results as recommendations.
0
Your basket
The basket is emptyBack to store
SEMAXPOLSKA - Chemical reagents
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.